{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:21:27Z","timestamp":1775686887326,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"DOI":"10.7759\/cureus.81570","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T20:01:11Z","timestamp":1743537671000},"source":"Crossref","is-referenced-by-count":2,"title":["Impact of Lifestyle Modifications Along With Pharmacological Treatment of Heart Failure: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Elizabeth Caroline","family":"Palaparthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arockiamary","family":"Ignasimuthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaoudam","family":"N","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagasaikaran","family":"Sade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Bade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharath Kumar","family":"Jakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khyathi Krishna","family":"Gogineni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjaneyulu","family":"Dunde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tambi","family":"Medabala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panneerselvam","family":"Periasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger RH","year":"2021","unstructured":"Schwinger RH. Pathophysiology of heart failure. Cardiovasc Diagn Ther. 2021, 11:263-76. 10.21037\/cdt-20-302","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America","volume":"29","author":"Bozkurt B","year":"2023","unstructured":"Bozkurt B, Ahmad T, Alexander KM, et al.. Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. J Card Fail. 2023, 29:1412-51. 10.1016\/j.cardfail.2023.07.006","journal-title":"J Card Fail"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese G","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017, 3:7-11. 10.15420\/cfr.2016:25:2","journal-title":"Card Fail Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666190709185011","article-title":"Contemporary pharmacologic management of heart failure with reduced ejection fraction: a review","volume":"16","author":"Egbuche O","year":"2020","unstructured":"Egbuche O, Hanna B, Onuorah I, Uko E, Taha Y, Ghali JK, Onwuanyi A. Contemporary pharmacologic management of heart failure with reduced ejection fraction: a review. Curr Cardiol Rev. 2020, 16:55-64. 10.2174\/1573403X15666190709185011","journal-title":"Curr Cardiol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.59497","article-title":"Racial and socioeconomic determinants of cardiovascular health: a comprehensive review","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Cureus. 2024, 16:e59497. 10.7759\/cureus.59497","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.36628\/ijhf.2022.0032","article-title":"Lifestyle modification in heart failure management: are we using evidence-based recommendations in real world practice?","volume":"5","author":"Camafort M","year":"2023","unstructured":"Camafort M, Park SM, Kang SM. Lifestyle modification in heart failure management: are we using evidence-based recommendations in real world practice?. Int J Heart Fail. 2023, 5:21-33. 10.36628\/ijhf.2022.0032","journal-title":"Int J Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.5627","article-title":"Interventions for optimization of guideline-directed medical therapy: a systematic review","volume":"9","author":"Tang AB","year":"2024","unstructured":"Tang AB, Brownell NK, Roberts JS, et al.. Interventions for optimization of guideline-directed medical therapy: a systematic review. JAMA Cardiol. 2024, 9:397-404. 10.1001\/jamacardio.2023.5627","journal-title":"JAMA Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/824135","article-title":"Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure","volume":"2013","author":"Komamura K","year":"2013","unstructured":"Komamura K. Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure. Cardiol Res Pract. 2013, 2013:824135. 10.1155\/2013\/824135","journal-title":"Cardiol Res Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2047487319870344","article-title":"Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies","volume":"27","author":"Aimo A","year":"2020","unstructured":"Aimo A, Castiglione V, Borrelli C, et al.. Oxidative stress and inflammation in the evolution of heart failure: from pathophysiology to therapeutic strategies. Eur J Prev Cardiol. 2020, 27:494-510. 10.1177\/2047487319870344","journal-title":"Eur J Prev Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60050760","article-title":"The role of oxidative stress and inflammatory parameters in heart failure","volume":"60","author":"Wr\u00f3bel-Nowicka K","year":"2024","unstructured":"Wr\u00f3bel-Nowicka K, Wojciechowska C, Jache\u0107 W, Zalewska M, Romuk E. The role of oxidative stress and inflammatory parameters in heart failure. Medicina (Kaunas). 2024, 60:760. 10.3390\/medicina60050760","journal-title":"Medicina (Kaunas)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt B","year":"2016","unstructured":"Bozkurt B, Aguilar D, Deswal A, et al.. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation. 2016, 134:e535-78. 10.1161\/CIR.0000000000000450","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure","volume":"316","author":"The Consensus Trial Study Group","year":"1987","unstructured":"The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987, 316:1429-35. 10.1056\/NEJM198706043162301","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray JJ","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, et al.. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014, 371:993-1004. 10.1056\/NEJMoa1409077","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8090101","article-title":"The use of \u03b2-blockers in heart failure with reduced ejection fraction","volume":"8","author":"Masarone D","year":"2021","unstructured":"Masarone D, Martucci ML, Errigo V, Pacileo G. The use of \u03b2-blockers in heart failure with reduced ejection fraction. J Cardiovasc Dev Dis. 2021, 8:101. 10.3390\/jcdd8090101","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae298","article-title":"Beta-blockers for secondary prevention following myocardial infarction in patients without reduced ejection fraction or heart failure: an updated meta-analysis","volume":"2024","author":"Chi KY","year":"2024","unstructured":"Chi KY, Lee PL, Chowdhury I, et al.. Beta-blockers for secondary prevention following myocardial infarction in patients without reduced ejection fraction or heart failure: an updated meta-analysis. Eur J Prev Cardiol. 2024, 2024:zwae298. 10.1093\/eurjpc\/zwae298","journal-title":"Eur J Prev Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert NM","year":"2009","unstructured":"Albert NM, Yancy CW, Liang L, et al.. Use of aldosterone antagonists in heart failure. JAMA. 2009, 302:1658-65. 10.1001\/jama.2009.1493","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2022.069","article-title":"Diuretics in the management of chronic heart failure: when and how","volume":"45","author":"Magdy JS","year":"2022","unstructured":"Magdy JS, McVeigh J, Indraratna P. Diuretics in the management of chronic heart failure: when and how. Aust Prescr. 2022, 45:200-4. 10.18773\/austprescr.2022.069","journal-title":"Aust Prescr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.36628\/ijhf.2022.0030","article-title":"SGLT-2 inhibitors in heart failure: a review of current evidence","volume":"5","author":"Talha KM","year":"2023","unstructured":"Talha KM, Anker SD, Butler J. SGLT-2 inhibitors in heart failure: a review of current evidence. Int J Heart Fail. 2023, 5:82-90. 10.36628\/ijhf.2022.0030","journal-title":"Int J Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2021.01.006","article-title":"Emerging pharmacologic therapies for heart failure with reduced ejection fraction","volume":"3","author":"Chaudhary AG","year":"2021","unstructured":"Chaudhary AG, Alreefi FM, Aziz MA. Emerging pharmacologic therapies for heart failure with reduced ejection fraction. CJC Open. 2021, 3:646-57. 10.1016\/j.cjco.2021.01.006","journal-title":"CJC Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2271","article-title":"Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)","volume":"23","author":"Savarese G","year":"2021","unstructured":"Savarese G, Bodegard J, Norhammar A, et al.. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Eur J Heart Fail. 2021, 23:1499-511. 10.1002\/ejhf.2271","journal-title":"Eur J Heart Fail"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2018.987","article-title":"Exercise training in patients with chronic heart failure: A new challenge for Cardiac Rehabilitation Community","volume":"88","author":"Giallauria F","year":"2018","unstructured":"Giallauria F, Piccioli L, Vitale G, Sarullo FM. Exercise training in patients with chronic heart failure: A new challenge for Cardiac Rehabilitation Community. Monaldi Arch Chest Dis. 2018, 88:987. 10.4081\/monaldi.2018.987","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/nu13124424","article-title":"Dietary management of heart failure: DASH diet and precision nutrition perspectives","volume":"13","author":"Wickman BE","year":"2021","unstructured":"Wickman BE, Enkhmaa B, Ridberg R, Romero E, Cadeiras M, Meyers F, Steinberg F. Dietary management of heart failure: DASH diet and precision nutrition perspectives. Nutrients. 2021, 13:4424. 10.3390\/nu13124424","journal-title":"Nutrients"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102730","article-title":"Omega-3 fatty acids in the treatment of heart failure","volume":"49","author":"Kelling M","year":"2024","unstructured":"Kelling M, Dimza M, Bartlett A, Traktuev DO, Duarte JD, Keeley EC. Omega-3 fatty acids in the treatment of heart failure. Curr Probl Cardiol. 2024, 49:102730. 10.1016\/j.cpcardiol.2024.102730","journal-title":"Curr Probl Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00611-7","article-title":"The role of cardiac rehabilitation in improving cardiovascular outcomes","volume":"19","author":"Taylor RS","year":"2022","unstructured":"Taylor RS, Dalal HM, McDonagh ST. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol. 2022, 19:180-94. 10.1038\/s41569-021-00611-7","journal-title":"Nat Rev Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2024.1302109","article-title":"High intensity interval training vs. moderate intensity continuous training on aerobic capacity and functional capacity in patients with heart failure: a systematic review and meta-analysis","volume":"11","author":"Yang C","year":"2024","unstructured":"Yang C, Zhang L, Cheng Y, et al.. High intensity interval training vs. moderate intensity continuous training on aerobic capacity and functional capacity in patients with heart failure: a systematic review and meta-analysis. Front Cardiovasc Med. 2024, 11:1302109. 10.3389\/FCVM.2024.1302109","journal-title":"Front Cardiovasc Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2018.31.1","article-title":"Exercise training and heart failure: a review of the literature","volume":"5","author":"Morris JH","year":"2019","unstructured":"Morris JH, Chen L. Exercise training and heart failure: a review of the literature. Card Fail Rev. 2019, 5:57-61. 10.15420\/cfr.2018.31.1","journal-title":"Card Fail Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.14797\/mdcvj.1511","article-title":"The impact of obesity on cardiovascular diseases: heart failure","volume":"21","author":"Alansari H","year":"2025","unstructured":"Alansari H, Lazzara G, Taha MB, Gorthi JR. The impact of obesity on cardiovascular diseases: heart failure. Methodist Debakey Cardiovasc J. 2025, 21:44-52. 10.14797\/mdcvj.1511","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.06.006","article-title":"Obesity and weight loss strategies for patients with heart failure","volume":"12","author":"Vest AR","year":"2024","unstructured":"Vest AR, Schauer PR, Rodgers JE, et al.. Obesity and weight loss strategies for patients with heart failure. JACC Heart Fail. 2024, 12:1509-27. 10.1016\/j.jchf.2024.06.006","journal-title":"JACC Heart Fail"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.12.047","article-title":"The pathophysiology of cigarette smoking and cardiovascular disease: an update","volume":"43","author":"Ambrose JA","year":"2004","unstructured":"Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004, 43:1731-7. 10.1016\/j.jacc.2003.12.047","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-008-0017-z","article-title":"Alcohol consumption and heart failure: a systematic review","volume":"10","author":"Djouss\u00e9 L","year":"2008","unstructured":"Djouss\u00e9 L, Gaziano JM. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep. 2008, 10:117-20. 10.1007\/s11883-008-0017-z","journal-title":"Curr Atheroscler Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2022.07.006","article-title":"Smoking cessation reduces the risk of heart failure: a nationwide cohort study","volume":"11","author":"Yoo JE","year":"2023","unstructured":"Yoo JE, Jeong SM, Yeo Y, et al.. Smoking cessation reduces the risk of heart failure: a nationwide cohort study. JACC Heart Fail. 2023, 11:277-87. 10.1016\/j.jchf.2022.07.006","journal-title":"JACC Heart Fail"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54402","article-title":"Understanding mental health challenges in cardiovascular care","volume":"16","author":"Borkowski P","year":"2024","unstructured":"Borkowski P, Borkowska N. Understanding mental health challenges in cardiovascular care. Cureus. 2024, 16:e54402. 10.7759\/cureus.54402","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2008","article-title":"Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology","volume":"23","author":"Jaarsma T","year":"2021","unstructured":"Jaarsma T, Hill L, Bayes-Genis A, et al.. Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2021, 23:157-74. 10.1002\/ejhf.2008","journal-title":"Eur J Heart Fail"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2011.06.003","article-title":"Psychiatric and behavioral aspects of cardiovascular disease: epidemiology, mechanisms, and treatment (Article in Spanish)","volume":"64","author":"Smith PJ","year":"2011","unstructured":"Smith PJ, Blumenthal JA. Psychiatric and behavioral aspects of cardiovascular disease: epidemiology, mechanisms, and treatment (Article in Spanish). Rev Esp Cardiol. 2011, 64:924-33. 10.1016\/j.recesp.2011.06.003","journal-title":"Rev Esp Cardiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.115.002243","article-title":"Psychosocial factors and risk of incident heart failure: the multi-ethnic study of atherosclerosis","volume":"9","author":"Ogilvie RP","year":"2016","unstructured":"Ogilvie RP, Everson-Rose SA, Longstreth WT Jr, Rodriguez CJ, Diez-Roux AV, Lutsey PL. Psychosocial factors and risk of incident heart failure: the multi-ethnic study of atherosclerosis. Circ Heart Fail. 2016, 9:e002243. 10.1161\/CIRCHEARTFAILURE.115.002243","journal-title":"Circ Heart Fail"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.01.030","article-title":"Cardiac rehabilitation for patients with heart failure: JACC expert panel","volume":"77","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Fonarow GC, Goldberg LR, et al.. Cardiac rehabilitation for patients with heart failure: JACC expert panel. J Am Coll Cardiol. 2021, 77:1454-69. 10.1016\/j.jacc.2021.01.030","journal-title":"J Am Coll Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-012-0367-6","article-title":"Exercise training in chronic heart failure: mechanisms and therapies","volume":"21","author":"Piepoli MF","year":"2013","unstructured":"Piepoli MF. Exercise training in chronic heart failure: mechanisms and therapies. Neth Heart J. 2013, 21:85-90. 10.1007\/s12471-012-0367-6","journal-title":"Neth Heart J"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13226993","article-title":"Non-pharmacological therapy in heart failure and management of heart failure in special populations-a review","volume":"13","author":"Dugal JK","year":"2024","unstructured":"Dugal JK, Malhi AS, Ramazani N, Yee B, DiCaro MV, Lei K. Non-pharmacological therapy in heart failure and management of heart failure in special populations-a review. J Clin Med. 2024, 13:6993. 10.3390\/jcm13226993","journal-title":"J Clin Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46243","article-title":"Exploring the cardiovascular benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors: expanding horizons beyond diabetes management","volume":"15","author":"Fatima A","year":"2023","unstructured":"Fatima A, Rasool S, Devi S, et al.. Exploring the cardiovascular benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors: expanding horizons beyond diabetes management. Cureus. 2023, 15:e46243. 10.7759\/cureus.46243","journal-title":"Cureus"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13030608","article-title":"The role of SGLT2-inhibitors across all stages of heart failure and mechanisms of early clinical benefit: from prevention to advanced heart failure","volume":"13","author":"Crispino SP","year":"2025","unstructured":"Crispino SP, Segreti A, Nafisio V, et al.. The role of SGLT2-inhibitors across all stages of heart failure and mechanisms of early clinical benefit: from prevention to advanced heart failure. Biomedicines. 2025, 13:608. 10.3390\/biomedicines13030608","journal-title":"Biomedicines"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46486","article-title":"Advancements in heart failure management: a comprehensive narrative review of emerging therapies","volume":"15","author":"Sapna F","year":"2023","unstructured":"Sapna F, Raveena F, Chandio M, et al.. Advancements in heart failure management: a comprehensive narrative review of emerging therapies. Cureus. 2023, 15:e46486. 10.7759\/cureus.46486","journal-title":"Cureus"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status","volume":"160","author":"Ma TK","year":"2010","unstructured":"Ma TK, Kam KK, Yan BP, Lam YY. Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol. 2010, 160:1273-92. 10.1111\/j.1476-5381.2010.00750.x","journal-title":"Br J Pharmacol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/7844.3983","article-title":"Effect of yoga therapy on heart rate, blood pressure and cardiac autonomic function in heart failure","volume":"8","author":"Krishna BH","year":"2014","unstructured":"Krishna BH, Pal P, Pal GK, et al.. Effect of yoga therapy on heart rate, blood pressure and cardiac autonomic function in heart failure. J Clin Diagn Res. 2014, 8:14-6. 10.7860\/JCDR\/2014\/7844.3983","journal-title":"J Clin Diagn Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.12.145","article-title":"Effect of exercise training on endothelial function in heart failure patients: a systematic review meta-analysis","volume":"231","author":"Pearson MJ","year":"2017","unstructured":"Pearson MJ, Smart NA. Effect of exercise training on endothelial function in heart failure patients: a systematic review meta-analysis. Int J Cardiol. 2017, 231:234-43. 10.1016\/j.ijcard.2016.12.145","journal-title":"Int J Cardiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2304148","article-title":"Exercise training after myocardial infarction attenuates dysfunctional ventricular remodeling and promotes cardiac recovery","volume":"23","author":"Liu S","year":"2022","unstructured":"Liu S, Meng X, Li G, Gokulnath P, Wang J, Xiao J. Exercise training after myocardial infarction attenuates dysfunctional ventricular remodeling and promotes cardiac recovery. Rev Cardiovasc Med. 2022, 23:148. 10.31083\/j.rcm2304148","journal-title":"Rev Cardiovasc Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1249\/JSR.0000000000000869","article-title":"Physical activity in the treatment and prevention of heart failure: an update","volume":"20","author":"LaMonte MJ","year":"2021","unstructured":"LaMonte MJ, Eaton CB. Physical activity in the treatment and prevention of heart failure: an update. Curr Sports Med Rep. 2021, 20:410-7. 10.1249\/JSR.0000000000000869","journal-title":"Curr Sports Med Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S90942","article-title":"Physical activity in patients with heart failure: barriers and motivations with special focus on sex differences","volume":"9","author":"Klompstra L","year":"2015","unstructured":"Klompstra L, Jaarsma T, Str\u00f6mberg A. Physical activity in patients with heart failure: barriers and motivations with special focus on sex differences. Patient Prefer Adherence. 2015, 9:1603-10. 10.2147\/PPA.S90942","journal-title":"Patient Prefer Adherence"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2010.08.002","article-title":"CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system","volume":"17","author":"Adamson PB","year":"2011","unstructured":"Adamson PB, Abraham WT, Aaron M, et al.. CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail. 2011, 17:3-10. 10.1016\/j.cardfail.2010.08.002","journal-title":"J Card Fail"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.18502\/ijph.v52i9.13566","article-title":"Effective strategies for physical activity adherence in heart failure patients: an umbrella review","volume":"52","author":"Moonaghi HK","year":"2023","unstructured":"Moonaghi HK, Ahrari S, Mahdizadeh SM, Bakavoli AH, Riahi SM. Effective strategies for physical activity adherence in heart failure patients: an umbrella review. Iran J Public Health. 2023, 52:1832-43. 10.18502\/ijph.v52i9.13566","journal-title":"Iran J Public Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/353579-impact-of-lifestyle-modifications-along-with-pharmacological-treatment-of-heart-failure-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T20:01:16Z","timestamp":1743537676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/353579-impact-of-lifestyle-modifications-along-with-pharmacological-treatment-of-heart-failure-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.81570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}